Location: Home > Pharma China Web Edition
  • search
  • go
  • Feature Articles
  • 9/3/2025China's Biopharma Industry Clusters: Mapping Opportunities and Regiona...
  • 9/2/2025China's Clinical Trial Quality Management Faces Key Challenges Despite...
  • 8/27/2025AstraZeneca Bounces Back from Scandal in China with $2.5B R&D Push
  • 8/27/2025Global Pharma Funnels $48.5B into Chinese Biotech Partnerships in H120...
  • 8/22/2025Premier Li Visits BeOne, Signaling China's Strategic Push for Biotech ...
  • 8/20/2025On the Cusp of a Cure: Is Asia Pacific Ready for the Precision Era? (C...
  • 8/19/2025Six Key Insights Into China Biotech's NewCo Model (Mondaq)
  • 8/19/2025Leaving China Manufacturing: The Hidden Risks And How To Protect Your ...
  • 8/19/2025Adjudication Of Drug Patent Linkage Cases When The Originator Drug's T...
  • 8/19/2025U.S. Tariffs Pressure Mounting, Japanese Pharma Looks East for Growth ...
  • 8/14/2025China Sees Surge in Innovative Drug Approvals in H1, Covering Cancer, ...
  • 8/13/2025The Trends Shaping Chinese Pharma Patent Litigation (Mondaq)
  • 8/8/2025China Biopharma Tracker – July 2025: Funding Surges and Major Deals (...
  • 8/8/2025Pharma MNCs in China H1/2025 – Mature Products Exit, Top Performers R...
  • 8/7/2025Innovation through Talent: How Leadership Is Evolving in China's Life ...
  • 8/6/2025Big Pharma Provides Lifeline to Chinese Companies Struggling To Surviv...
  • 8/6/2025Novartis Heart Drug A China Case Study: How Drug Exclusivity Dies by a...
  • 8/1/2025What the Latest Volume-Based Procurement Changes in China Mean for Pha...
  • 7/31/2025China's Plan to Boost Drug Coverage by Commercial Insurers No 'Magic W...
  • 7/29/2025US Drug Supply Chain Exposure to China (Brookings)
  • 7/23/2025Accelerating US Oncology Drug Development Using Chinese First-in-Human...
  • 7/22/2025PharmaDJ's China Biopharma Tracker – June 2025 (PharmaDJ)
  • 7/12/2025Analysing Key Trends In China's Patent-linkage System and Their Impact...
  • 7/10/2025China's Rising Biotechnology Sector: Friend or Foe? (EGGI)
  • 7/8/2025As Chinese-developed Drugs Draw U.S. Interest, A Regulatory Chill Thre...
  • 7/2/2025FDA's Crackdown and China's Dealmaking: Warning Signs or Business as U...
  • 7/2/2025Medical Advances Soar With APAC's Clinical Trial Growth (BioSpectrum)
  • 7/1/2025Tracking the Crossroads of Policy, Innovation, and Global Biotech Inve...
  • 7/1/2025BeOne Launches Phase III Trial Comparing Subcutaneous and Intravenous ...
  • 7/1/2025China Launches Landmark Measures to Boost Innovative Drug Industry, Se...
  • Page:1/7 Total number of articles:188: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group